Statins were linked to a 15% lower risk of glaucoma after five years, and a 10% lower risk after ten years. Researchers reviewed medical records from about 210,000 people over age 40 who used Statins, medicines that lower cholesterol. They compared them with a matched group who had never used these medicines. The study looked at new glaucoma diagnoses and the need for eye procedures. Glaucoma damages the nerve that carries sight signals to the brain. It affects about 95 million people worldwide and can cause permanent sight loss. For the Blurred Vision community, the key distinction is lower disease risk, not proven symptom relief. People using these medicines also had a lower risk of needing glaucoma procedures. At five years, the risk of surgery involving an incision was 36% lower. The risk of less invasive surgery was 55% lower. For one laser treatment, it was 60% lower. At ten years, those figures were 32%, 46%, and 51% lower, respectively. These results show a link, not proof that the medicines caused the difference. The source does not give the starting risk for either group. So the percentages do not tell us how many people avoided glaucoma. For members tracking symptoms, this offers context rather than a treatment target. A shared log could include symptom dates, medicine history, and eye exam results. Comparing those records with community peers may help organize experiences. It cannot establish that a medicine improved vision or prevented disease. What have you noticed when comparing your vision symptoms, medicine history, and eye exam results over time?